25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Anixa Biosciences Inc
Buy, Hold or Sell?

Let's analyze Anixa together

I guess you are interested in Anixa Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Anixa Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Anixa Biosciences Inc

I send you an email if I find something interesting about Anixa Biosciences Inc.

1. Quick Overview

1.1. Quick analysis of Anixa (30 sec.)










1.2. What can you expect buying and holding a share of Anixa? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$0.64
Expected worth in 1 year
$0.52
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.12
Return On Investment
-3.9%

For what price can you sell your share?

Current Price per Share
$3.14
Expected price per share
$2.95 - $4.1
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Anixa (5 min.)




Live pricePrice per Share (EOD)
$3.14
Intrinsic Value Per Share
$-3.25 - $-2.43
Total Value Per Share
$-2.61 - $-1.79

2.2. Growth of Anixa (5 min.)




Is Anixa growing?

Current yearPrevious yearGrowGrow %
How rich?$20.6m$26.4m-$3.8m-17.0%

How much money is Anixa making?

Current yearPrevious yearGrowGrow %
Making money-$3m-$2.5m-$574.7k-18.6%
Net Profit Margin-431.1%-242.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Anixa (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#544 / 950

Most Revenue
#711 / 950

Most Profit
#355 / 950

Most Efficient
#614 / 950
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Anixa?

Welcome investor! Anixa's management wants to use your money to grow the business. In return you get a share of Anixa.

First you should know what it really means to hold a share of Anixa. And how you can make/lose money.

Speculation

The Price per Share of Anixa is $3.14. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anixa.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anixa, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.64. Based on the TTM, the Book Value Change Per Share is $-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anixa.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-3.2%-0.10-3.1%-0.08-2.6%-0.09-2.9%-0.08-2.4%
Usd Book Value Change Per Share-0.06-1.9%-0.03-1.0%-0.05-1.6%0.020.8%0.020.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.06-1.9%-0.03-1.0%-0.05-1.6%0.020.8%0.020.5%
Usd Price Per Share3.32-3.50-4.41-3.69-3.42-
Price to Earnings Ratio-8.15--9.11--13.49--10.55--9.46-
Price-to-Total Gains Ratio-56.53-98.33--98.54-0.42--119.56-
Price to Book Ratio5.16-4.98-5.35-7.69-17.16-
Price-to-Total Gains Ratio-56.53-98.33--98.54-0.42--119.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.14
Number of shares318
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.030.02
Usd Total Gains Per Share-0.030.02
Gains per Quarter (318 shares)-9.627.56
Gains per Year (318 shares)-38.4830.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-38-4803020
20-77-8606050
30-115-12409180
40-154-1620121110
50-192-2000151140
60-231-2380181170
70-269-2760212200
80-308-3140242230
90-346-3520272260
100-385-3900302290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.038.00.05.0%5.0134.00.03.6%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%6.014.00.030.0%13.027.00.032.5%47.084.08.033.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%7.00.0132.05.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%6.014.00.030.0%13.027.00.032.5%48.084.07.034.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Anixa Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.059-0.030-48%-0.049-16%0.024-347%0.016-468%
Book Value Per Share--0.6430.701-8%0.820-22%0.689-7%0.416+54%
Current Ratio--11.31213.353-15%17.422-35%15.870-29%10.844+4%
Debt To Asset Ratio--0.0970.081+20%0.065+50%0.091+7%0.273-65%
Debt To Equity Ratio--0.1020.084+21%0.067+52%0.098+3%0.495-79%
Dividend Per Share----0%-0%-0%0.000-100%
Eps---0.102-0.096-6%-0.082-19%-0.090-11%-0.076-25%
Free Cash Flow Per Share---0.082-0.065-21%-0.045-45%-0.049-40%-0.036-57%
Free Cash Flow To Equity Per Share---0.078-0.037-52%-0.048-39%0.071-209%0.037-310%
Gross Profit Margin--1.0011.0020%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---2.434--------
Intrinsic Value_10Y_min---3.253--------
Intrinsic Value_1Y_max---0.157--------
Intrinsic Value_1Y_min---0.230--------
Intrinsic Value_3Y_max---0.539--------
Intrinsic Value_3Y_min---0.779--------
Intrinsic Value_5Y_max---1.000--------
Intrinsic Value_5Y_min---1.418--------
Market Cap101043630.000-6%106835940.000112547801.250-5%141911595.000-25%118790624.250-10%109914633.214-3%
Net Profit Margin----4.3110%-2.4230%-0.3210%-3.3810%
Operating Margin----4.8890%-3.0480%-0.6100%-3.3440%
Operating Ratio---4.909-100%3.298-100%0.527-100%3.484-100%
Pb Ratio4.883-6%5.1634.984+4%5.345-3%7.687-33%17.160-70%
Pe Ratio-7.709+5%-8.150-9.108+12%-13.487+65%-10.554+29%-9.461+16%
Price Per Share3.140-6%3.3203.498-5%4.410-25%3.692-10%3.416-3%
Price To Free Cash Flow Ratio-9.558+5%-10.106-13.811+37%-26.656+164%-20.692+105%-24.864+146%
Price To Total Gains Ratio-53.462+5%-56.52798.326-157%-98.541+74%0.423-13474%-119.563+112%
Quick Ratio--20.29724.747-18%29.454-31%22.623-10%15.196+34%
Return On Assets---0.143-0.126-12%-0.089-38%-0.165+16%-0.219+53%
Return On Equity---0.151-0.132-13%-0.092-39%-0.179+19%-0.298+98%
Total Gains Per Share---0.059-0.030-48%-0.049-16%0.024-347%0.016-459%
Usd Book Value--20691000.00022561750.000-8%26402500.000-22%22160066.750-7%13400815.850+54%
Usd Book Value Change Per Share---0.059-0.030-48%-0.049-16%0.024-347%0.016-468%
Usd Book Value Per Share--0.6430.701-8%0.820-22%0.689-7%0.416+54%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps---0.102-0.096-6%-0.082-19%-0.090-11%-0.076-25%
Usd Free Cash Flow---2643000.000-2094250.000-21%-1458250.000-45%-1577929.650-40%-1145436.000-57%
Usd Free Cash Flow Per Share---0.082-0.065-21%-0.045-45%-0.049-40%-0.036-57%
Usd Free Cash Flow To Equity Per Share---0.078-0.037-52%-0.048-39%0.071-209%0.037-310%
Usd Market Cap101043630.000-6%106835940.000112547801.250-5%141911595.000-25%118790624.250-10%109914633.214-3%
Usd Price Per Share3.140-6%3.3203.498-5%4.410-25%3.692-10%3.416-3%
Usd Profit---3277000.000-3090250.000-6%-2515500.000-23%-2877812.400-12%-2391743.500-27%
Usd Revenue---39000.000-100%617302500.000-100%123655407.950-100%61865575.550-100%
Usd Total Gains Per Share---0.059-0.030-48%-0.049-16%0.024-347%0.016-459%
 EOD+3 -5MRQTTM+2 -30YOY+5 -275Y+6 -2610Y+14 -20

3.3 Fundamental Score

Let's check the fundamental score of Anixa Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.709
Price to Book Ratio (EOD)Between0-14.883
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than120.297
Current Ratio (MRQ)Greater than111.312
Debt to Asset Ratio (MRQ)Less than10.097
Debt to Equity Ratio (MRQ)Less than10.102
Return on Equity (MRQ)Greater than0.15-0.151
Return on Assets (MRQ)Greater than0.05-0.143
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Anixa Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.357
Ma 20Greater thanMa 503.259
Ma 50Greater thanMa 1003.237
Ma 100Greater thanMa 2003.210
OpenGreater thanClose3.260
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Anixa Biosciences Inc

Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR- T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer " primarily triple negative breast cancer (TNBC), the lethal form of the disease, as well as a vaccine to prevent ovarian cancer. Its vaccine technologies focus on immunizing against retired proteins that found to be expressed in certain forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Fundamental data was last updated by Penke on 2024-11-14 10:09:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Anixa earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Anixa to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anixa Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-431.1%+431.1%
TTM-431.1%YOY-242.3%-188.8%
TTM-431.1%5Y-32.1%-399.0%
5Y-32.1%10Y-338.1%+306.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--112.2%+112.2%
TTM-431.1%-221.4%-209.7%
YOY-242.3%-210.0%-32.3%
5Y-32.1%-342.2%+310.1%
10Y-338.1%-464.5%+126.4%
4.3.1.2. Return on Assets

Shows how efficient Anixa is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anixa to the Biotechnology industry mean.
  • -14.3% Return on Assets means that Anixa generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anixa Biosciences Inc:

  • The MRQ is -14.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.3%TTM-12.6%-1.7%
TTM-12.6%YOY-8.9%-3.8%
TTM-12.6%5Y-16.5%+3.9%
5Y-16.5%10Y-21.9%+5.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.3%-11.3%-3.0%
TTM-12.6%-11.7%-0.9%
YOY-8.9%-11.3%+2.4%
5Y-16.5%-12.7%-3.8%
10Y-21.9%-14.1%-7.8%
4.3.1.3. Return on Equity

Shows how efficient Anixa is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anixa to the Biotechnology industry mean.
  • -15.1% Return on Equity means Anixa generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anixa Biosciences Inc:

  • The MRQ is -15.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-13.2%-1.9%
TTM-13.2%YOY-9.2%-4.0%
TTM-13.2%5Y-17.9%+4.8%
5Y-17.9%10Y-29.8%+11.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.1%-14.2%-0.9%
TTM-13.2%-15.9%+2.7%
YOY-9.2%-14.3%+5.1%
5Y-17.9%-18.5%+0.6%
10Y-29.8%-19.3%-10.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Anixa Biosciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Anixa is operating .

  • Measures how much profit Anixa makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anixa to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anixa Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-488.9%+488.9%
TTM-488.9%YOY-304.8%-184.1%
TTM-488.9%5Y-61.0%-428.0%
5Y-61.0%10Y-334.4%+273.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--222.9%+222.9%
TTM-488.9%-310.7%-178.2%
YOY-304.8%-223.5%-81.3%
5Y-61.0%-387.1%+326.1%
10Y-334.4%-498.5%+164.1%
4.3.2.2. Operating Ratio

Measures how efficient Anixa is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.909-4.909
TTM4.909YOY3.298+1.611
TTM4.9095Y0.527+4.381
5Y0.52710Y3.484-2.957
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.465-2.465
TTM4.9093.253+1.656
YOY3.2983.2980.000
5Y0.5274.788-4.261
10Y3.4846.494-3.010
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Anixa Biosciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Anixa is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 11.31 means the company has $11.31 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 11.312. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.353. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.312TTM13.353-2.041
TTM13.353YOY17.422-4.069
TTM13.3535Y15.870-2.517
5Y15.87010Y10.844+5.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3123.637+7.675
TTM13.3533.890+9.463
YOY17.4224.666+12.756
5Y15.8705.953+9.917
10Y10.8446.277+4.567
4.4.3.2. Quick Ratio

Measures if Anixa is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Anixa to the Biotechnology industry mean.
  • A Quick Ratio of 20.30 means the company can pay off $20.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 20.297. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 24.747. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ20.297TTM24.747-4.450
TTM24.747YOY29.454-4.707
TTM24.7475Y22.623+2.123
5Y22.62310Y15.196+7.427
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.2973.086+17.211
TTM24.7473.451+21.296
YOY29.4544.456+24.998
5Y22.6235.931+16.692
10Y15.1966.436+8.760
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Anixa Biosciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Anixa assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Anixa to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Anixa assets are financed with 9.7% credit (debt) and the remaining percentage (100% - 9.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 0.097. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.081. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.097TTM0.081+0.016
TTM0.081YOY0.065+0.016
TTM0.0815Y0.091-0.010
5Y0.09110Y0.273-0.183
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0970.350-0.253
TTM0.0810.344-0.263
YOY0.0650.310-0.245
5Y0.0910.365-0.274
10Y0.2730.382-0.109
4.5.4.2. Debt to Equity Ratio

Measures if Anixa is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Anixa to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.2% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 0.102. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.084. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.102TTM0.084+0.018
TTM0.084YOY0.067+0.017
TTM0.0845Y0.098-0.014
5Y0.09810Y0.495-0.396
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1020.394-0.292
TTM0.0840.432-0.348
YOY0.0670.380-0.313
5Y0.0980.451-0.353
10Y0.4950.490+0.005
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Anixa generates.

  • Above 15 is considered overpriced but always compare Anixa to the Biotechnology industry mean.
  • A PE ratio of -8.15 means the investor is paying $-8.15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anixa Biosciences Inc:

  • The EOD is -7.709. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.150. Based on the earnings, the company is expensive. -2
  • The TTM is -9.108. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.709MRQ-8.150+0.442
MRQ-8.150TTM-9.108+0.958
TTM-9.108YOY-13.487+4.379
TTM-9.1085Y-10.554+1.446
5Y-10.55410Y-9.461-1.093
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.709-2.303-5.406
MRQ-8.150-2.403-5.747
TTM-9.108-3.148-5.960
YOY-13.487-3.251-10.236
5Y-10.554-6.084-4.470
10Y-9.461-6.764-2.697
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anixa Biosciences Inc:

  • The EOD is -9.558. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.106. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.811. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.558MRQ-10.106+0.548
MRQ-10.106TTM-13.811+3.706
TTM-13.811YOY-26.656+12.845
TTM-13.8115Y-20.692+6.881
5Y-20.69210Y-24.864+4.172
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.558-3.042-6.516
MRQ-10.106-3.234-6.872
TTM-13.811-3.719-10.092
YOY-26.656-4.557-22.099
5Y-20.692-8.332-12.360
10Y-24.864-9.276-15.588
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Anixa is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.16 means the investor is paying $5.16 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anixa Biosciences Inc:

  • The EOD is 4.883. Based on the equity, the company is fair priced.
  • The MRQ is 5.163. Based on the equity, the company is overpriced. -1
  • The TTM is 4.984. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.883MRQ5.163-0.280
MRQ5.163TTM4.984+0.179
TTM4.984YOY5.345-0.361
TTM4.9845Y7.687-2.703
5Y7.68710Y17.160-9.473
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.8831.943+2.940
MRQ5.1632.051+3.112
TTM4.9842.356+2.628
YOY5.3452.454+2.891
5Y7.6873.714+3.973
10Y17.1604.378+12.782
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anixa Biosciences Inc.

4.8.1. Institutions holding Anixa Biosciences Inc

Institutions are holding 17.385% of the shares of Anixa Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Vanguard Group Inc4.32860.0001139290600
2024-06-30Davidson D A & Co2.28850.01447364157364150
2024-06-30Laird Norton Tyee Trust Co1.87770.188360423500
2024-06-30UBS Group AG1.64870.0003530540-5767-1.0753
2024-06-30Mission Wealth Management, LLC1.56130.029450242000
2024-06-30Geode Capital Management, LLC1.02730.0001330575104273.2569
2024-06-30Bank of America Corp0.6741021691410000085.533
2024-06-30Long Focus Capital Management, LLC0.51490.01416570100
2024-06-30BlackRock Inc0.4985016041657543.7204
2024-06-30Susquehanna International Group, LLP0.34930.0001112393-228558-67.0354
2024-06-30State Street Corp0.3477011190034003.1336
2024-06-30Bank of New York Mellon Corp0.227073050-14000-16.0827
2024-06-30Northern Trust Corp0.2208071040837813.3701
2024-06-30Morgan Stanley - Brokerage Accounts0.2144069002-5270-7.0955
2024-06-30CoreCap Advisors, LLC0.14570.01084689426005.8699
2024-06-30CAMBRIDGE Invest RESEARCH ADVISORS, INC.0.12740.00034100000
2024-09-30International Assets Investment Management, LLC0.11750.03293780023800170
2024-06-30CI Private Wealth LLC0.11620.00013740000
2024-06-30Gemmer Asset Management LLC0.10880.00833500000
2024-06-30LPL Financial Corp0.0972031292460017.2336
Total 16.49160.29915306893+641779+12.1%

4.9.2. Funds holding Anixa Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Vanguard Total Stock Mkt Idx Inv2.88330.000292784100
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr1.30720.001242065800
2024-09-30Fidelity Extended Market Index0.54730.0013176124-11734-6.2462
2024-09-30BlackRock Extended Equity Market K0.22650.001672899-31-0.0425
2024-10-31iShares Micro-Cap ETF0.22440.02817222100
2024-09-30Fidelity Total Market Index0.16070.000251703-127-0.245
2024-09-30Fidelity Series Total Market Index0.12770.00024109900
2024-09-30Northern Trust Extended Eq Market Idx0.10780.00153467400
2024-09-30NT Ext Equity Mkt Idx Fd - L0.10780.00153467400
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.10720.00163450900
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.08640.001627804850.3066
2024-09-30Fidelity Nasdaq Composite Index0.07490.00042410200
2024-03-31Vanguard Instl Ttl Stck Mkt Idx Tr0.06550.00022107900
2024-09-30Vanguard Instl Ttl Stk Mkt Idx InstlPls0.06550.00022107900
2024-09-30Spartan Extended Market Index Pool E0.05710.001318386-2143-10.4389
2024-09-30Spartan Total Market Index Pool E0.05330.0002171381270.7466
2024-09-30Schwab Total Stock Market Index0.03970.00021278500
2024-09-30Vanguard Balanced Index Inv0.03920.00011259900
2024-09-30Vanguard U.S. Eq Idx £ Acc0.03330.00021072900
2024-09-30Extended Equity Market Fund M0.02870.00169250-23-0.248
Total 6.34350.04342041353-13846-0.7%

5.3. Insider Transactions

Insiders are holding 5.046% of the shares of Anixa Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-07-30Lewis H Titterton JrBUY216463.06
2024-07-26Arnold M BaskiesBUY50003.09
2024-06-13Lewis H Titterton JrBUY4052.7
2024-06-10Lewis H Titterton JrBUY3302.6
2024-06-07Amit KumarBUY250002.41
2024-06-07Lewis H Titterton JrBUY107382.52
2024-06-07Michael CatelaniBUY62502.4
2024-04-09Lewis H Titterton JrBUY150093.28
2024-03-15Amit KumarBUY300003.22
2024-03-15Arnold M BaskiesBUY100003.63
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-07-31. Currency in USD. All numbers in thousands.

Summary
Total Assets22,908
Total Liabilities2,217
Total Stockholder Equity21,771
 As reported
Total Liabilities 2,217
Total Stockholder Equity+ 21,771
Total Assets = 22,908

Assets

Total Assets22,908
Total Current Assets22,670
Long-term Assets238
Total Current Assets
Cash And Cash Equivalents 1,225
Short-term Investments 19,520
Net Receivables 410
Other Current Assets 1,515
Total Current Assets  (as reported)22,670
Total Current Assets  (calculated)22,670
+/-0
Long-term Assets
Property Plant Equipment 238
Long-term Assets Other 0
Long-term Assets  (as reported)238
Long-term Assets  (calculated)238
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,004
Long-term Liabilities213
Total Stockholder Equity21,771
Total Current Liabilities
Short-term Debt 24
Accounts payable 302
Other Current Liabilities 1,678
Total Current Liabilities  (as reported)2,004
Total Current Liabilities  (calculated)2,004
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt213
Long-term Liabilities  (as reported)213
Long-term Liabilities  (calculated)213
+/-0
Total Stockholder Equity
Common Stock321
Retained Earnings -237,867
Other Stockholders Equity 259,317
Total Stockholder Equity (as reported)21,771
Total Stockholder Equity (calculated)21,771
+/-0
Other
Capital Stock321
Cash and Short Term Investments 20,745
Common Stock Shares Outstanding 32,054
Liabilities and Stockholders Equity 22,908
Net Debt -988
Net Invested Capital 21,771
Net Working Capital 20,666
Property Plant and Equipment Gross 238
Short Long Term Debt Total 237



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-07-312024-04-302024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-12-012017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-10-312015-07-312015-04-302015-01-312014-10-312014-07-312014-04-302014-01-312013-10-312013-07-312013-04-302013-01-312012-10-312012-07-312012-04-302012-01-312011-10-312011-07-312011-04-302011-01-312010-10-312010-07-312010-04-302010-01-312009-10-312009-07-312009-04-302009-01-312008-10-312008-07-312008-04-302008-01-312007-10-312007-07-312007-04-302007-01-312006-10-312006-07-312006-04-302006-01-312005-10-312005-07-312005-04-302005-01-312004-10-312004-07-312004-04-302004-01-312003-10-312003-07-312003-04-302003-01-312002-10-312002-07-312002-04-302002-01-312001-10-312001-07-312001-04-302001-01-312000-10-312000-07-312000-04-302000-01-311999-10-311999-07-311999-04-301999-01-311998-10-311998-07-311998-04-301998-01-311997-10-311997-07-311997-04-301997-01-311996-10-311996-07-311996-04-301996-01-311995-10-311995-07-311995-04-301995-01-311994-10-311994-07-311994-04-301994-01-311993-10-311993-07-311993-04-301993-01-311992-10-311992-07-311992-04-301992-01-311991-10-311991-07-311991-04-301991-01-311990-10-311990-07-311990-04-301990-01-311989-10-311989-07-311989-04-301989-01-311988-10-311988-07-311988-04-301988-01-311987-10-311987-07-311987-04-301987-01-311986-10-311986-07-311986-04-301986-01-311985-10-31
> Total Assets 
3,300
0
0
0
1,500
0
0
0
1,200
0
0
0
2,100
0
0
0
4,200
4,200
4,200
4,200
4,200
4,300
4,200
4,200
4,300
4,500
4,500
4,300
4,400
5,700
6,000
7,900
8,700
7,700
7,200
7,400
6,600
6,000
7,200
9,400
9,700
11,500
15,400
23,400
24,700
23,100
22,500
21,400
20,000
18,300
16,300
15,000
13,300
12,700
11,700
10,500
8,100
8,100
9,740
9,302
6,895
6,302
5,771
7,542
6,562
8,737
7,381
3,575
2,732
2,732
1,826
2,331
2,330
2,131
2,516
2,281
2,316
2,347
2,068
1,756
1,466
1,646
1,696
1,601
1,864
2,048
1,977
1,820
1,870
24,283
21,204
14,624
7,498
6,054
6,008
8,077
9,848
9,711
10,175
8,625
10,046
10,046
8,627
10,169
8,646
8,029
6,794
5,887
5,661
7,522
7,354
5,308
5,440
10,327
10,500
13,399
9,055
13,270
11,133
10,279
9,336
8,647
7,206
6,321
5,628
4,219
7,249
8,415
8,812
8,812,416
7,491
7,361
7,294
6,449
6,470
7,765
6,843
6,294
6,164
5,925
9,362
9,453
14,604
38,498
37,062
36,257
35,238
32,797
32,563
30,412
28,306
27,599
26,578
25,522
25,372
24,355
22,908
22,90824,35525,37225,52226,57827,59928,30630,41232,56332,79735,23836,25737,06238,49814,6049,4539,3625,9256,1646,2946,8437,7656,4706,4497,2947,3617,4918,812,4168,8128,4157,2494,2195,6286,3217,2068,6479,33610,27911,13313,2709,05513,39910,50010,3275,4405,3087,3547,5225,6615,8876,7948,0298,64610,1698,62710,04610,0468,62510,1759,7119,8488,0776,0086,0547,49814,62421,20424,2831,8701,8201,9772,0481,8641,6011,6961,6461,4661,7562,0682,3472,3162,2812,5162,1312,3302,3311,8262,7322,7323,5757,3818,7376,5627,5425,7716,3026,8959,3029,7408,1008,10010,50011,70012,70013,30015,00016,30018,30020,00021,40022,50023,10024,70023,40015,40011,5009,7009,4007,2006,0006,6007,4007,2007,7008,7007,9006,0005,7004,4004,3004,5004,5004,3004,2004,2004,3004,2004,2004,2004,2004,2000002,1000001,2000001,5000003,300
   > Total Current Assets 
3,000
0
0
0
1,100
0
0
0
700
0
0
0
1,900
0
0
0
4,000
4,000
4,100
4,000
4,000
4,100
4,000
4,100
4,200
4,300
4,300
4,100
4,200
5,500
5,800
7,600
8,400
7,400
6,800
7,100
6,300
5,700
6,900
8,800
9,000
10,300
14,000
21,500
22,600
21,000
20,600
19,600
18,200
16,700
14,800
13,700
9,000
8,600
7,700
7,200
7,500
7,600
9,310
8,952
3,655
3,121
2,641
4,549
3,580
5,753
4,445
3,480
2,654
2,654
1,768
2,280
2,285
2,089
2,476
2,241
2,272
2,305
2,029
1,720
1,434
1,611
1,566
1,364
1,623
1,597
1,524
1,368
1,416
1,553
1,622
2,316
2,257
2,831
2,386
2,179
2,396
2,122
1,974
1,528
1,235
1,235
1,785
3,644
3,120
2,610
1,788
1,145
922
1,780
1,326
1,029
1,234
3,367
3,630
6,435
6,322
10,571
8,523
7,754
6,896
6,187
4,801
4,006
3,400
2,069
5,192
6,446
7,014
7,013,940
5,775
5,721
5,720
5,538
6,236
7,494
6,628
6,093
5,869
5,657
9,264
9,369
14,564
38,472
37,052
36,003
34,994
32,563
32,340
30,200
28,105
27,410
26,400
25,356
25,219
24,214
22,670
22,67024,21425,21925,35626,40027,41028,10530,20032,34032,56334,99436,00337,05238,47214,5649,3699,2645,6575,8696,0936,6287,4946,2365,5385,7205,7215,7757,013,9407,0146,4465,1922,0693,4004,0064,8016,1876,8967,7548,52310,5716,3226,4353,6303,3671,2341,0291,3261,7809221,1451,7882,6103,1203,6441,7851,2351,2351,5281,9742,1222,3962,1792,3862,8312,2572,3161,6221,5531,4161,3681,5241,5971,6231,3641,5661,6111,4341,7202,0292,3052,2722,2412,4762,0892,2852,2801,7682,6542,6543,4804,4455,7533,5804,5492,6413,1213,6558,9529,3107,6007,5007,2007,7008,6009,00013,70014,80016,70018,20019,60020,60021,00022,60021,50014,00010,3009,0008,8006,9005,7006,3007,1006,8007,4008,4007,6005,8005,5004,2004,1004,3004,3004,2004,1004,0004,1004,0004,0004,1004,0004,0000001,9000007000001,1000003,000
       Cash And Cash Equivalents 
2,800
0
0
0
1,000
0
0
0
700
0
0
0
1,700
0
0
0
2,200
2,500
1,700
2,200
2,100
2,100
3,000
2,100
4,100
4,300
4,300
4,100
4,100
5,400
5,800
7,600
8,300
7,400
6,800
7,000
6,200
5,700
6,900
8,700
8,900
10,200
13,900
21,400
22,200
19,500
18,500
15,800
12,300
11,200
8,000
6,100
5,400
4,400
3,700
2,300
1,600
2,100
3,589
2,621
1,134
703
158
2,016
1,317
3,455
2,142
1,302
855
855
408
1,057
1,024
868
1,243
1,040
1,003
1,012
641
582
507
809
732
611
1,282
828
766
653
669
794
764
458
479
1,716
1,291
321
1,451
1,197
1,075
1,409
1,094
1,094
347
551
774
463
131
102
340
1,713
1,274
982
898
776
618
3,652
3,361
7,810
6,080
5,161
4,369
3,981
2,612
2,049
2,488
1,400
2,877
1,834
3,339
3,339,374
2,847
4,172
2,591
3,056
4,153
3,822
4,397
3,492
2,822
2,888
5,928
6,417
11,983
27,703
27,222
29,128
29,781
27,732
24,254
12,360
9,790
5,620
3,198
915
998
995
1,225
1,2259959989153,1985,6209,79012,36024,25427,73229,78129,12827,22227,70311,9836,4175,9282,8882,8223,4924,3973,8224,1533,0562,5914,1722,8473,339,3743,3391,8342,8771,4002,4882,0492,6123,9814,3695,1616,0807,8103,3613,6526187768989821,2741,7133401021314637745513471,0941,0941,4091,0751,1971,4513211,2911,7164794587647946696537668281,2826117328095075826411,0121,0031,0401,2438681,0241,0574088558551,3022,1423,4551,3172,0161587031,1342,6213,5892,1001,6002,3003,7004,4005,4006,1008,00011,20012,30015,80018,50019,50022,20021,40013,90010,2008,9008,7006,9005,7006,2007,0006,8007,4008,3007,6005,8005,4004,1004,1004,3004,3004,1002,1003,0002,1002,1002,2001,7002,5002,2000001,7000007000001,0000002,800
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
500
0
97
97
97
97
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
396
398
401
403
398
398
38
425
425
400
400
441
441
1,440
1,442
750
750
1,650
750
750
750
0
0
0
1,349
2,999
2,249
2,050
1,550
950
500
500
0
0
0
2,450
2,050
2,550
2,500
2,650
2,400
2,400
2,400
2,150
2,150
1,900
750
600
2,250
4,251
3,500
3,500,000
2,650
1,250
2,750
2,000
1,750
2,750
2,100
2,350
2,870
2,620
3,140
2,640
2,000
10,399
9,400
6,600
4,749
4,499
7,410
17,327
17,912
21,356
22,336
22,929
22,800
22,244
19,520
19,52022,24422,80022,92922,33621,35617,91217,3277,4104,4994,7496,6009,40010,3992,0002,6403,1402,6202,8702,3502,1002,7501,7502,0002,7501,2502,6503,500,0003,5004,2512,2506007501,9002,1502,1502,4002,4002,4002,6502,5002,5502,0502,4500005005009501,5502,0502,2492,9991,3490007507507501,6507507501,4421,4404414414004004254253839839840340139839600000000000000009797979705005000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
478
595
561
708
694
536
562
507
525
401
401
215
177
169
140
145
150
148
288
99
173
62
30
68
37
10
69
60
60
120
60
191
207
103
112
106
12
1
1
8
5
0
0
0
0
0
0
0
0
0
0
0
0
175
175
828
133
400
45
0
0
0
0
0
0
0
0
0
221
0
0
0
0
0
307
0
797
1
67
22
32
6
2
0
0
0
0
0
0
0
46
147
256
334
270
391
218
410
41021839127033425614746000000026322267179703070000022100000000045400133828175175000000000000581112106112103207191601206060691037683062173992881481501451401691772154014015255075625366947085615954780000000000000000000000000000000000000000001,8000000000000000000
       Inventory 
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
0
3,000
2,800
3,600
4,500
4,400
4,360
4,868
1,769
1,834
1,761
1,620
1,589
1,497
1,601
1,517
1,296
1,296
1,032
1,028
1,045
1,036
1,064
1,033
999
977
877
555
385
330
308
281
261
243
231
214
192
225
196
185
178
177
176
138
133
110
93
59
52
52
32
33
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-46
0
0
0
0
0
0
0
0000000-460000000000000000000000000000000000000000000003332525259931101331381761771781851962251922142312432612813083303855558779779991,0331,0641,0361,0451,0281,0321,2961,2961,5171,6011,4971,5891,6201,7611,8341,7694,8684,3604,4004,5003,6002,8003,00001,80000000000000000000000000000000000000000000000000000100
       Other Current Assets 
100
0
0
0
100
0
0
0
0
0
0
0
200
0
0
0
0
1,500
2,400
1,800
1,900
2,000
1,000
2,000
100
0
0
0
100
100
0
0
100
0
0
100
100
0
0
100
100
100
100
100
400
1,500
2,100
3,800
5,900
5,500
6,800
5,800
3,600
1,200
1,200
800
900
1,100
1,264
888
60
23
14
219
137
239
194
137
103
103
113
17
48
45
23
18
122
27
17
12
401
38
60
36
32
32
42
41
35
33
30
26
54
77
63
58
62
65
48
56
89
89
57
61
97
97
107
93
82
67
52
47
161
141
134
101
61
66
43
194
127
56
39
56
162
69
65
140
175
0
278
298
378
482
334
124
130
185
154
116
190
309
581
369
430
276
464
332
676
513
256
178
532
1,242
1,030
757
1,515
1,5157571,0301,2425321782565136763324642764303695813091901161541851301243344823782982780175140656916256395612719443666110113414116147526782931079797615789895648656258637754263033354142323236603840112172712218234548171131031031371942391372191423608881,2641,1009008001,2001,2003,6005,8006,8005,5005,9003,8002,1001,5004001001001001001000010010000100001001000001002,0001,0002,0001,9001,8002,4001,50000002000000000100000100
   > Long-term Assets 
300
0
0
0
400
0
0
0
500
0
0
0
200
0
0
0
200
200
100
200
200
200
200
100
100
200
200
200
200
200
200
300
300
300
400
300
300
300
300
600
700
1,200
1,400
1,900
2,100
2,100
1,900
1,800
1,800
1,600
1,500
1,300
4,300
4,100
4,000
3,300
600
500
430
350
3,239
3,181
3,130
2,993
2,983
2,984
2,936
96
77
77
58
52
45
41
40
40
44
42
39
35
32
36
130
238
241
450
453
452
455
22,729
19,582
12,308
5,241
3,223
3,621
5,898
7,452
7,589
8,202
7,096
0
8,811
6,842
6,524
5,525
5,420
5,006
4,742
4,739
5,742
6,028
4,278
4,206
6,960
6,870
6,964
2,734
2,699
2,610
2,525
2,440
2,461
2,404
2,316
2,228
2,150
2,058
1,969
1,798
0
1,715
1,640
1,574
910
234
272
215
201
295
268
98
84
40
26
10
254
244
234
223
212
201
189
178
166
153
141
238
23814115316617818920121222323424425410264084982682952012152722349101,5741,6401,71501,7981,9692,0582,1502,2282,3162,4042,4612,4402,5252,6102,6992,7346,9646,8706,9604,2064,2786,0285,7424,7394,7425,0065,4205,5256,5246,8428,81107,0968,2027,5897,4525,8983,6213,2235,24112,30819,58222,7294554524534502412381303632353942444040414552587777962,9362,9842,9832,9933,1303,1813,2393504305006003,3004,0004,1004,3001,3001,5001,6001,8001,8001,9002,1002,1001,9001,4001,200700600300300300300400300300300200200200200200200100100200200200200100200200000200000500000400000300
       Property Plant Equipment 
300
0
0
0
300
0
0
0
300
0
0
0
200
0
0
0
100
100
100
100
100
100
100
100
-500
100
-500
100
100
100
100
100
200
200
200
200
200
200
200
200
200
200
500
500
800
900
900
900
900
900
900
800
800
700
700
600
500
500
403
325
270
212
162
129
119
121
103
84
72
72
53
46
39
36
35
34
38
37
33
30
27
31
28
26
23
22
25
24
27
31
33
31
30
27
24
24
21
19
17
15
15
15
19
18
16
15
14
12
10
11
8
9
8
8
8
10
12
59
51
47
43
146
171
163
157
160
149
141
53
52,701
51
57
72
73
67
230
215
201
295
268
68
54
40
26
10
254
244
234
223
212
201
189
178
166
153
141
238
2381411531661781892012122232342442541026405468268295201215230677372575152,701531411491601571631711464347515912108889811101214151618191515151719212424273031333127242522232628312730333738343536394653727284103121119129162212270325403500500600700700800800900900900900900900800500500200200200200200200200200200200100100100100100-500100-500100100100100100100100100000200000300000300000300
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,506
5,510
5,405
4,992
4,730
4,728
5,731
6,021
4,269
4,197
3,986
3,977
4,151
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000004,1513,9773,9864,1974,2696,0215,7314,7284,7304,9925,4055,5106,5060000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,966
2,884
2,803
2,722
2,640
2,559
2,478
2,396
2,315
2,234
2,152
2,071
1,990
1,908
1,827
1,746
0
1,664
1,583
1,502
838
168
42
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000421688381,5021,5831,66401,7461,8271,9081,9902,0712,1522,2342,3152,3962,4782,5592,6402,7222,8032,8842,96600000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
26
25
2,970
2,969
2,968
2,864
2,863
2,863
2,833
11
6
6
5
5
6
6
6
6
6
5
6
5
5
5
102
211
218
428
428
428
427
22,699
19,549
12,277
5,211
3,196
3,598
5,874
7,431
7,570
8,184
7,082
8,796
7,155
6,823
6,507
5,510
5,405
4,992
4,730
4,729
5,731
6,021
4,270
4,197
6,952
6,862
6,954
2,721
2,640
2,559
2,478
2,397
2,315
2,234
2,152
2,071
1,990
1,908
1,827
1,746
0
1,665
1,583
1,503
838
0
0
0
0
0
0
30
84
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000084300000008381,5031,5831,66501,7461,8271,9081,9902,0712,1522,2342,3152,3972,4782,5592,6402,7216,9546,8626,9524,1974,2706,0215,7314,7294,7304,9925,4055,5106,5076,8237,1558,7967,0828,1847,5707,4315,8743,5983,1965,21112,27719,54922,69942742842842821821110255565666665566112,8332,8632,8632,8642,9682,9692,970252627000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
200
0
0
0
200
0
0
0
100
0
0
0
100
0
0
0
100
100
100
100
100
100
100
100
100
200
200
200
300
300
400
300
500
600
400
300
200
300
300
200
300
500
500
800
1,900
1,500
1,300
1,500
1,200
1,300
1,100
1,400
1,400
1,400
1,300
1,600
1,800
2,000
2,075
2,335
1,337
1,269
1,147
3,202
2,396
4,114
1,535
394
414
414
421
390
342
383
408
360
443
422
293
270
348
472
372
292
582
367
328
320
679
5,587
5,483
6,594
5,768
5,680
5,456
5,212
5,396
5,391
5,389
5,492
5,450
5,450
5,552
7,927
7,588
7,291
7,133
6,780
6,855
8,846
8,800
8,545
8,760
15,997
15,346
13,250
5,046
5,013
4,143
4,282
4,282
5,056
4,646
4,603
4,641
8,037
3,660
2,927
889
8,812,416
1,087
1,340
1,129
1,265
1,327
1,596
1,444
1,481
1,166
1,103
1,224
1,189
1,525
1,443
1,208
1,491
1,996
1,391
1,656
2,212
1,394
1,686
1,993
2,151
1,768
1,774
2,217
2,2171,7741,7682,1511,9931,6861,3942,2121,6561,3911,9961,4911,2081,4431,5251,1891,2241,1031,1661,4811,4441,5961,3271,2651,1291,3401,0878,812,4168892,9273,6608,0374,6414,6034,6465,0564,2824,2824,1435,0135,04613,25015,34615,9978,7608,5458,8008,8466,8556,7807,1337,2917,5887,9275,5525,4505,4505,4925,3895,3915,3965,2125,4565,6805,7686,5945,4835,5876793203283675822923724723482702934224433604083833423904214144143941,5354,1142,3963,2021,1471,2691,3372,3352,0752,0001,8001,6001,3001,4001,4001,4001,1001,3001,2001,5001,3001,5001,900800500500300200300300200300400600500300400300300200200200100100100100100100100100100000100000100000200000200
   > Total Current Liabilities 
200
0
0
0
200
0
0
0
100
0
0
0
100
0
0
0
100
100
100
100
100
100
200
100
200
200
200
200
300
200
400
300
400
600
400
300
200
300
300
200
200
400
600
700
2,000
1,500
1,400
1,500
1,200
1,300
1,100
1,400
1,500
1,400
1,300
1,600
1,800
2,000
2,075
2,335
1,337
1,269
1,147
3,202
2,396
4,114
1,535
394
414
414
421
390
342
383
408
360
443
422
293
270
348
472
372
292
582
367
328
320
679
587
483
1,594
768
680
456
212
396
391
389
492
450
450
552
2,927
2,105
2,055
2,133
1,780
1,822
3,439
3,301
3,095
3,212
11,548
10,682
8,357
1,810
1,667
689
712
594
1,244
707
532
469
3,724
3,660
2,927
889
889,493
1,087
1,340
1,129
1,265
1,327
1,596
1,444
1,481
1,126
1,077
1,213
1,189
1,525
1,443
1,208
1,271
1,787
1,189
1,469
2,037
1,232
1,537
1,857
2,028
1,660
1,681
2,004
2,0041,6811,6602,0281,8571,5371,2322,0371,4691,1891,7871,2711,2081,4431,5251,1891,2131,0771,1261,4811,4441,5961,3271,2651,1291,3401,087889,4938892,9273,6603,7244695327071,2445947126891,6671,8108,35710,68211,5483,2123,0953,3013,4391,8221,7802,1332,0552,1052,9275524504504923893913962124566807681,5944835876793203283675822923724723482702934224433604083833423904214144143941,5354,1142,3963,2021,1471,2691,3372,3352,0752,0001,8001,6001,3001,4001,5001,4001,1001,3001,2001,5001,4001,5002,000700600400200200300300200300400600400300400200300200200200200100200100100100100100100000100000100000200000200
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
582
610
691
957
5,668
5,000
5,000
0
0
0
0
0
0
0
0
0
3,000
3,000
2,000
0
0
0
0
0
0
0
0
0
0
53
56
58
55
41
26
11
39
41
39
44
46
47
49
51
52
54
56
24
2456545251494746443941391126415558565300000000002,0003,0003,0000000000005,0005,0005,6689576916105820000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
100
100
100
100
200
200
200
300
200
400
300
400
600
400
300
200
200
300
200
200
400
500
700
2,000
1,500
1,400
1,500
1,200
1,300
1,100
1,400
1,400
1,200
1,200
1,300
1,500
1,700
1,949
2,167
1,036
1,045
940
815
816
548
410
341
379
379
380
353
317
334
374
323
403
398
252
231
271
404
313
253
533
318
199
244
347
403
424
308
385
470
294
104
326
315
304
390
356
356
456
278
375
449
559
463
305
489
534
516
527
492
458
529
540
578
389
425
375
560
418
445
469
541
448
445
480
0
417
452
419
582
613
718
568
586
367
171
339
232
512
438
208
136
504
93
227
265
110
195
94
206
364
215
302
302215364206941951102652279350413620843851223233917136758656871861358241945241704804454485414694454185603754253895785405294584925275165344893054635594493752784563563563903043153261042944703853084244033472441993185332533134042712312523984033233743343173533803793793414105488168159401,0451,0362,1671,9491,7001,5001,3001,2001,2001,4001,4001,1001,3001,2001,5001,4001,5002,00070050040020020030020020030040060040030040020030020020020010010010010010010010010000000000000000000
       Other Current Liabilities 
200
0
0
0
200
0
0
0
100
0
0
0
100
0
0
0
100
0
0
0
0
0
100
0
100
0
0
0
0
0
0
0
0
0
0
0
0
100
0
0
0
0
100
0
0
0
0
0
0
0
0
0
100
200
100
300
300
300
126
168
301
224
206
220
38
57
41
53
35
35
42
37
25
49
34
37
40
24
41
39
77
68
59
39
49
49
129
76
332
184
59
56
69
210
161
108
70
76
86
103
94
94
96
75
86
162
140
130
331
1,180
970
700
540
4,201
4,037
1,900
1,269
1,090
300
287
219
684
289
87
96
183
212
482
409
0
670
888
710
683
714
878
876
895
705
850
816
901
973
979
990
1,095
1,242
1,057
1,198
1,726
1,075
1,293
1,712
1,770
1,242
1,410
1,678
1,6781,4101,2421,7701,7121,2931,0751,7261,1981,0571,2421,095990979973901816850705895876878714683710888670040948221218396872896842192873001,0901,2691,9004,0374,2015407009701,180331130140162867596949410386767010816121069565918433276129494939596877394124403734492537423535534157382202062243011681263003003001002001000000000001000000100000000000000100010000000100000100000100000200000200
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
100
-100
100
-100
200
200
200
300
100
400
300
100
600
400
300
200
200
300
200
100
100
-100
100
-100
1,500
-100
1,500
1,200
1,300
1,100
1,400
-100
1,200
1,200
1,300
1,500
1,700
1,949
2,167
1,036
1,045
940
2,982
2,358
4,057
1,494
341
0
379
380
353
317
334
374
323
403
398
252
231
271
404
313
253
533
318
199
244
347
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
0
5,000
5,000
5,000
5,483
5,236
5,000
5,000
5,032
5,408
5,499
5,451
5,549
4,449
4,664
4,893
3,236
3,345
3,454
3,570
3,688
3,812
3,939
4,071
4,172
4,313
3,448
2,445
480
0
409,169
452
419
582
613
718
568
586
41
26
11
288
553
464
218
220
209
202
187
175
162
149
136
123
108
93
213
21393108123136149162175187202209220218464553288112641586568718613582419452409,16904802,4453,4484,3134,1724,0713,9393,8123,6883,5703,4543,3453,2364,8934,6644,4495,5495,4515,4995,4085,0325,0005,0005,2365,4835,0005,0005,00005,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,00034724419931853325331340427123125239840332337433431735338037903411,4944,0572,3582,9829401,0451,0362,1671,9491,7001,5001,3001,2001,200-1001,4001,1001,3001,2001,500-1001,500-100100-100100100200300200200300400600100300400100300200200200-100100-10010010010010010000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
408
454
451
549
1,512
1,627
1,756
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000001,7561,6271,51254945145440832000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483
236
0
0
0
0
46
0
0
2,937
3,037
3,136
3,236
3,346
3,454
3,569
3,688
3,812
3,939
4,071
4,172
4,313
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000004,3134,1724,0713,9393,8123,6883,5693,4543,3463,2363,1363,0372,9370046000023648300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483
236
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000023648300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
3,100
0
0
0
1,300
0
0
0
1,100
0
0
0
2,000
0
0
0
4,100
4,100
4,100
4,100
4,100
4,200
4,100
4,100
4,200
4,300
4,300
4,100
4,100
5,400
5,600
7,600
8,200
7,100
6,800
7,100
6,400
5,700
6,900
9,200
9,400
11,000
14,900
22,600
22,800
21,600
21,200
19,900
18,800
17,000
15,200
13,600
11,900
11,300
10,400
8,900
6,300
6,100
7,664
6,967
5,558
5,033
4,624
4,340
4,167
4,623
5,846
3,182
2,317
2,317
1,405
1,941
1,988
1,747
2,108
1,920
1,873
1,925
1,775
1,486
1,118
1,174
1,325
1,309
1,282
1,680
1,649
1,500
1,191
18,696
15,720
8,030
1,730
374
552
2,865
4,452
4,320
4,786
3,132
4,596
4,596
3,075
2,241
1,058
738
-339
-893
-1,194
-1,324
-1,446
-3,238
-3,321
-5,669
-4,846
150
4,010
8,258
6,990
5,998
5,054
3,591
2,560
1,718
987
-3,819
3,589
5,488
7,923
0
6,436
6,066
6,326
5,435
5,479
6,543
5,799
5,235
5,445
5,287
8,618
8,761
13,600
37,614
36,467
35,437
33,963
32,171
31,701
29,047
27,791
26,811
25,520
24,337
24,605
23,623
21,771
21,77123,62324,60524,33725,52026,81127,79129,04731,70132,17133,96335,43736,46737,61413,6008,7618,6185,2875,4455,2355,7996,5435,4795,4356,3266,0666,43607,9235,4883,589-3,8199871,7182,5603,5915,0545,9986,9908,2584,010150-4,846-5,669-3,321-3,238-1,446-1,324-1,194-893-3397381,0582,2413,0754,5964,5963,1324,7864,3204,4522,8655523741,7308,03015,72018,6961,1911,5001,6491,6801,2821,3091,3251,1741,1181,4861,7751,9251,8731,9202,1081,7471,9881,9411,4052,3172,3173,1825,8464,6234,1674,3404,6245,0335,5586,9677,6646,1006,3008,90010,40011,30011,90013,60015,20017,00018,80019,90021,20021,60022,80022,60014,90011,0009,4009,2006,9005,7006,4007,1006,8007,1008,2007,6005,6005,4004,1004,1004,3004,3004,2004,1004,1004,2004,1004,1004,1004,1004,1000002,0000001,1000001,300